Zobrazeno 1 - 10
of 47
pro vyhledávání: '"B-M Emanuelsson"'
Publikováno v:
Acta Anaesthesiologica Scandinavica. 42:890-896
Background: Ropivacaine has shown less systemic toxicity than bupivacaine, and comparatively low muscle-blocking properties could constitute another advantage when used epidurally for obstetric pain relief. We aimed primarily to compare maternal and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae92b9c2dcd11261edf8e8176dafed6c
https://doi.org/10.1111/j.1399-6576.1998.tb05347.x
https://doi.org/10.1111/j.1399-6576.1998.tb05347.x
Publikováno v:
European Journal of Pharmaceutical Sciences. 5:171-177
The aim was to study the pharmacokinetic equivalence of the local anaesthetic ropivacaine and its stable isotope analogue [2H3]-ropivacaine. Ropivacaine (40.0–53.0 mg) and [2H3]-ropivacaine (41.9–52.4 mg) were given simultaneously to eight health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2654daf70225953b2b0d276a123a1c8a
https://doi.org/10.1016/s0928-0987(97)00274-1
https://doi.org/10.1016/s0928-0987(97)00274-1
Autor:
Ola Fjellström, B. Kull, Magnus Andersson, J. C. Ulvinge, J. A. Björkman, Tor Skärby, N. Oakes, Sven Nylander, B. M. Emanuelsson, T. Inghardt, David Gustafsson
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 10(10)
Nylander S, Kull B, Bjorkman JA, Ulvinge JC, Oakes N, Emanuelsson BM, Andersson M, Skarby T, Inghardt T, Fjellstrom O, Gustafsson D. Human target validation of phosphoinositide 3-kinase (PI3K)β:effects on platelets and insulin sensitivity, using AZD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4b7a4baa9634f3ac991e71320f22ac
https://pubmed.ncbi.nlm.nih.gov/22943292
https://pubmed.ncbi.nlm.nih.gov/22943292
Autor:
J.A.W. Wildsmith, H. Jozwiak, M.S. Brockway, Dermot W. McKeown, J.H. Mcclure, L. M. M. Morrison, A.J. Pollok, B-M Emanuelsson
Publikováno v:
British Journal of Anaesthesia. 72:164-169
Ninety-one patients were allocated randomly to three groups to receive 1% ropivacaine 10 ml, 0.5% ropivacaine 20 ml or 0.5% bupivacaine 20 ml extradurally. Intermittent sensory (pinprick) and motor (Bromage scale) assessments of the block produced we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75b7ebbee338ceb875ae481dcb1cb39
https://doi.org/10.1093/bja/72.2.164
https://doi.org/10.1093/bja/72.2.164
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 33(11)
1. The absorption of the flame retardant decabromodiphenyl ether (BDE-209) has been shown by its detection in human plasma, but reported experimental data on its determined in rat, and qualitative analyses by GC/MS of metabolites in plasma were perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe36485094f587d6a34c816f2c64b17
https://pubmed.ncbi.nlm.nih.gov/14660178
https://pubmed.ncbi.nlm.nih.gov/14660178
Publikováno v:
Acta anaesthesiologica Scandinavica. 47(7)
Neuropathic pain is often severe and resistant to pharmacological treatment. The aims of the present study were to assess the analgesic effect of ketamine and lidocaine and to investigate if measurement of different variables of sensibility could be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::24e9982584e0d4ab696d464b92a51554
https://pubmed.ncbi.nlm.nih.gov/12859309
https://pubmed.ncbi.nlm.nih.gov/12859309
Publikováno v:
Regional anesthesia and pain medicine. 24(2)
Ropivacaine is a long-acting local anesthetic similar to bupivacaine, but with lower cardiac toxicity and intrinsic vasoconstrictive properties that may reduce the risk and extent of systemic plasma absorption. Plasma levels and risks are associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1f3a0ac110839c5ef5093e88a2c050a0
https://pubmed.ncbi.nlm.nih.gov/10204899
https://pubmed.ncbi.nlm.nih.gov/10204899
Publikováno v:
Regional anesthesia and pain medicine. 23(2)
Background and ObjectivesEarly data on ropivacaine, a recently introduced local anesthetic, indicate a longer duration of skin analgesia than with bupivacaine, along with lower toxicity. The objective of this study was to evaluate ropivacaine 7.5 mg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30114974447f1bc17de7537732f65899
https://pubmed.ncbi.nlm.nih.gov/9570609
https://pubmed.ncbi.nlm.nih.gov/9570609
Publikováno v:
Acta anaesthesiologica Scandinavica. 41(9)
Background: The new, long-acting local anaesthetic ropivacaine has shown less systemic toxicity than bupivacaine and a concentration of 7.5 mg/ml can therefore be used for epidural anaesthesia in Caesarean section. The present pilot study was underta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8198347f25d72fac9018259bf514428d
https://pubmed.ncbi.nlm.nih.gov/9366935
https://pubmed.ncbi.nlm.nih.gov/9366935
Autor:
Frederick W. Burgess, Carol A. Stephenson, B. M. Emanuelsson, Randall L. Carpenter, Michael F. Mulroy
Publikováno v:
Anesthesiology. 81:A1015
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04b6f484da86f8adbc60d5fbc63d7088
https://doi.org/10.1097/00000542-199409001-01014
https://doi.org/10.1097/00000542-199409001-01014